11 12/20 11/12/2020

Latest Covid-19 Developments

Pfizer/ BioNTech’s vaccine has been administered to the first British citizen after being approved for emergency use last week. As mentioned in the previous newsletter, the vaccine will be administered to the vulnerable first. This first case was a 90-year-old woman. Besides the U.K there are more Western countries that started administering COVID-19 vaccines. Russia started administering its Sputnik V vaccine last Saturday and more than 1 million Chinese have been vaccinated with their proprietary vaccine.

Some American experts are questioning why the Pfizer/ BioNTech vaccine approval process takes so long. The emergency use application has been submitted since November the 20th but the decision is still not known. However, it is expected to be known later today. U.K. on the other hand approved the same exact vaccine a week ago and Canada approved it last Wednesday. In the meanwhile, the U.S. is still breaking records with their COVID-19 daily hospitalization rate and death rate.

The FDA found the Pfizer/ BioNTech vaccine to be highly effective in preventing COVID-19 using a single dose. For full efficacy, two doses must be administered three weeks apart. An FDA panel recommended Pfizer's COVID-19 vaccine for emergency use yesterday. The decision to approve or not approve the vaccine can be made known as early as today. In other news, the AstraZeneca/ Oxford vaccine was peer-reviewed and was concluded to be 70% effective in preventing COVID-19 infection.

Archive

News

Archive

© 2008 - 2021 All Rights Reserved. Solar Asset Management